Ypsomed Holding Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Ypsomed Holding hat ein Gesamteigenkapital von CHF617.7M und eine Gesamtverschuldung von CHF256.0M, wodurch sich der Verschuldungsgrad auf 41.4% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen CHF1.1B bzw. CHF483.7M. Ypsomed Holding Das EBIT des Unternehmens beträgt CHF86.2M, so dass der Zinsdeckungsgrad 18.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von CHF74.0M.

Wichtige Informationen

41.4%

Verhältnis von Schulden zu Eigenkapital

CHF 256.00m

Verschuldung

Zinsdeckungsgrad	18.5x
Bargeld	CHF 74.02m
Eigenkapital	CHF 617.74m
Gesamtverbindlichkeiten	CHF 483.66m
Gesamtvermögen	CHF 1.10b

Jüngste Berichte zur Finanzlage

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Jan 17

Recent updates

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Aug 13

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jul 31

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Jul 03

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Jun 19

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Jun 10

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

May 25

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

May 08

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Apr 07

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Mar 09

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

Feb 07

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Jan 23

Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear

Jan 08

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Dec 23

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?

Dec 05

Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?

Sep 28

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Sep 10

Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital

Aug 23

Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?

Aug 08

Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?

Jun 13

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

May 28

What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

May 06

Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital

Apr 21

At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?

Feb 01

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Jan 17

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Dec 27

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Nov 24

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Oct 19

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching

Jul 14

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jun 20

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?

Feb 28

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: YPSNDie kurzfristigen Aktiva des Unternehmens (CHF337.9M) decken seine kurzfristigen Passiva (CHF440.2M) nicht.

Langfristige Verbindlichkeiten: YPSNDie kurzfristigen Vermögenswerte des Unternehmens (CHF337.9M) übersteigen seine langfristigen Verbindlichkeiten (CHF43.4M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: YPSNDie Nettoverschuldung im Verhältnis zum Eigenkapital (29.5%) wird als zufriedenstellend angesehen.

Schulden abbauen: YPSNDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 32.2% auf 41.4% gestiegen.

Schuldendeckung: YPSNDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (63.8%).

Zinsdeckung: YPSNDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (18.5x Coverage) gut gedeckt.

Ypsomed Holding Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Recent updates

New minor risk - Share price stability

Ypsomed Group and CamDiab Receives Health Canada Approval for mylife YpsoPump and CamAPS FX and Provide an Enhancing Diabetes Management

Now 23% undervalued

Now 21% undervalued

Ypsomed Holding AG to Report First Half, 2025 Results on Nov 13, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Price target increased by 7.6% to CHF378

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

Full year 2024 earnings released: EPS: CHF5.74 (vs CHF3.82 in FY 2023)

Investor sentiment improves as stock rises 17%

Ypsomed Holding AG to Report Q4, 2024 Results on May 22, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Price target increased by 14% to CHF365

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?

First half 2024 earnings released: EPS: CHF2.68 (vs CHF1.17 in 1H 2023)

Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?

Price target increased by 14% to CHF315

Ypsomed Holding AG to Report First Half, 2024 Results on Nov 15, 2023

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital

Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?

Ypsomed Holding AG, Annual General Meeting, Jun 26, 2024

Upcoming dividend of €1.30 per share at 0.5% yield

Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?

Consensus EPS estimates increase by 15%

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Price target increased by 13% to CHF257

Ypsomed Holding AG to Report Fiscal Year 2023 Results on May 24, 2023

What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital

Ypsomed Holding AG, Annual General Meeting, Jun 28, 2023

At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Price target increased to CHF223

Mediq B.V. completed the acquisition of DiaExpert GmbH from Ypsomed Holding AG (SWX:YPSN).

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Investor sentiment deteriorated over the past week

Now 21% undervalued

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Consensus forecasts updated

Price target increased to CHF207

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

No independent directors

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Price target decreased to CHF192

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching

Upcoming dividend of CHF0.60 per share

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Full year 2022 earnings: EPS in line with analyst expectations despite revenue beat

Ypsomed Holding AG to Report Fiscal Year 2022 Results on May 25, 2022

Price target increased to CHF218

No independent directors

Now 20% undervalued after recent price drop

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?

Now 21% undervalued

Consensus EPS estimates increase by 32%

Now 20% undervalued

Price target increased to CHF178

First half 2022 earnings released